← Eichor
Condition: Cxcr4 Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cxcr4

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Ga-68-CXCR4 PET/CT in Indolent B-cell Lymphoma
Phase 2 · 1 location(s) · Koo Foundation Sun Yat-Sen Cancer Center · NCT06461182
Assessement of Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients
NA · 1 location(s) · Institut Cancerologie de l'Ouest · NCT06962163
The Role of Cxcr4Hi neutrOPhils in InflueNza
Phase N/A · 2 location(s) · University Hospital, Bordeaux · NCT06254313
Study Assessing RLT Using [177Lu]Lu-PentixaTher for Relapsed/Refractory CXCR4+ Acute Leukemia.
Phase 1/Phase 2 · 4 location(s) · Nantes University Hospital · NCT06356922
CXCR4-targeted PET/CT Imaging in Hematological Malignancies
NA · 1 location(s) · Zhongnan Hospital · NCT05255926
Lymphatic Organs and Myocardium After Myocardial Infarction
NA · 2 location(s) · Wuerzburg University Hospital · NCT05519735
Single Microdose Trial- CXCR4 PET Tracer - Pharmacokinetics and Pharmacodynamics of [68Ga]Ga-R54, a Radiopharmaceutical
EARLY_Phase 1 · 1 location(s) · National Cancer Institute, Naples · NCT07577206
PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Mye
NA · 1 location(s) · University Health Network, Toronto · NCT06871176
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
EARLY_Phase 1 · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT05093335
Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases
NA · 1 location(s) · Tianjin Medical University · NCT06690736
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropeni
Phase 3 · 114 location(s) · X4 Pharmaceuticals · NCT06056297
Diagnostic Value of CXCR4-targeted PET/CT in ACTH-dependent and Independent Cushing's Syndrome
Phase 1/Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT07350707
Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases
EARLY_Phase 1 · 1 location(s) · First Affiliated Hospital of Fujian Medical University · NCT04504526
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.